IL6 and metabolic dysfunction-associated steatohepatitis: Reports have shown differentiated gene expression profiles for various HCC etiologies; molecular classification of HCC has helped to identify a subgroup of HCC tumors with a highly activated IL6–JAK–STAT signaling pathway that are more commonly associated with nonalcoholic steatohepatitis and alcoholic steatohepatitis (32).